SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Lab21 Announces Exciting Companion Diagnostic Partnership

26 Jun 2012
Sonia Nicholas
Managing Editor and Clinical Lead

Product news

Lab21 Limited, has entered into an agreement with one of the world’s leading pharmaceutical companies (as yet unnamed) to develop, manufacture and distribute a new companion diagnostic assay. The assay will detect specific mutations in colorectal cancer samples, to enable selection of patients for the partner company’s therapeutic monoclonal antibody.

Under the agreement Lab21 will use its molecular diagnostic development resource and proprietary SPARQ™ PCR technology together with its expertise in the oncology diagnostic market to develop, manufacture and distribute the assay. In addition, the Company will provide specific sample analysis service from its accredited laboratory in Cambridge, UK on behalf of the partner.

Graham Mullis, CEO of Lab21, commented: “We are pleased to enter into a new companion diagnostic assay partnership with a major pharma company to develop and co-brand this assay. Lab21 has significant experience in molecular diagnostics in the oncology setting and the combination of this with our proven assay development capability, regulatory and manufacturing know-how has been recognised by a major pharma in order to better support the stratified patient requirements of their drug.”

Berwyn Clarke, CSO of Lab21, added: “As global regulatory authorities drive the requirement for linked companion diagnostic assays for licenced drugs this necessitates very close co-operation between pharmaceutical and diagnostic businesses. Lab21 is intent on providing efficient development of cost-effective, market-leading biomarker products to its pharmaceutical partners using its extensive experience in both nucleic-acid and protein-based diagnostics. The outcome of this new partnership will be a new assay which matches the best quality that is currently on the market, combined with more user-friendly performance and greater cost-effectiveness”

The assay will be based on Lab21’s recently acquired and proprietary SPARQTM PCR Technology and will be co-branded with the partner. It is understood that this is the first example of a pharmaceutical company co-branding a companion diagnostic. Lab21 expects to launch the product during the current year under the OnconosticaTM brand name and is expected to be the first of a pipe-line of new companion diagnostic assays.

Tags

Gas ChromatographyGas chromatography (GC) is an analytical technique used to separate and quantitate mixtures of small and volatile compounds. Gas chromatographs or GC systems include components such as GC columns, detectors, pumps and autosamplers. Choose from packed or capillary GC columns, flame ionization (FID), photoionization (PID) electron capture detectors and selective or non-selective detectors. Find the best gas chromatographs in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.UHPLC and HPLCHigh performance liquid chromatography (HPLC) and ultra high performance liquid chromatography (UHPLC), also known as UPLC, are analytical techniques used to separate, identify and quantitate components of complex mixtures including biological samples such as proteins and lipids as well as chemical mixtures of pesticides, drugs and oils. Both techniques are liquid chromatographic methods but differ by operating pressures (HPLC < 6000 psi < UHPLC ). Components of HPLC and UHPLC systems include columns, detectors, pumps, autosamplers and column heaters. Explore a range of UHPLC and HPLC columns for your specific sample needs including reverse phase, normal phase, ion exchange, HILIC, ion exclusion and size exclusion columns. For more specialized HPLC, explore FPLC, countercurrent LC and simulated moving bed systems. Find the best UHPLC and HPLC equipment in our peer reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Gene Expression and Molecular CloningMolecular cloning is a set of techniques that utilizes vectors to transfer recombinant DNA into host cells and is an essential tool for investigating the expression of genes and proteins in bacterial or mammalian cells. A variety of vectors optimized for gene cloning and expression in a range of host organisms are available, alongside competent cells for genetic replication. Here, you can explore a range of molecular tools, high-quality genomic and cDNA libraries, premade clones, transformation and transfection reagents and mutagenesis or gene expression detection assays and expression arrays. Find the best gene expression and molecular cloning products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Companion DiagnosticsCompanion diagnostics are tests, often <i>in vitro</i>, that are used to determine whether a therapeutic product will be safe and effective for use on an individual. They also identify which patients will benefit most from them. Companion diagnostic tests are often developed in conjunction with the pharmaceutical industry.Colorectal Cancer

Related articles